Health and Fitness Health and Fitness
Wed, July 18, 2012
[ Wed, Jul 18th 2012 ] - Market Wire
Discovery Labs Receives US Patent for Method to Promote Mucus Clearance with Pulmonary Surfactant
[ Wed, Jul 18th 2012 ] - Market Wire
Life Technologies Moving quot;;Off the Gridquot;; with Clean Energy Fuel Cells
[ Wed, Jul 18th 2012 ] - Market Wire
Uroplasty Announces Coverage Of Percutaneous Tibi .. s Urgent PC Neuromodulation System From EmblemHea
[ Wed, Jul 18th 2012 ] - Market Wire
Titan Medical Inc. Announces Issuance of U.S. Patent
[ Wed, Jul 18th 2012 ] - Market Wire
ViiV Healthcare Expands Commitment to Addressing .. ps in Paediatric HIV Research, Care and Treatment
Tue, July 17, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
Baker Brothers notify of 6.5% shareholding in Galapagos
[ Tue, Jul 17th 2012 ] - Market Wire
3SBio Inc. Schedules Unaudited Second Quarter 2012 Results
[ Tue, Jul 17th 2012 ] - Market Wire
Vivus Announces FDA Approval of Once Daily Qsymia .. ine and Topiramate Extended-release) Capsules CIV
[ Tue, Jul 17th 2012 ] - Market Wire
Law Office of Brodsky amp;; Smith, LLC Ann .. nces Investigation of Human Genome Sciences, Inc.
[ Tue, Jul 17th 2012 ] - Market Wire
Extendicare Announces 2012 Second Quarter Financi .. onference Call Information and Discontinues Moody
[ Tue, Jul 17th 2012 ] - Market Wire
Leisureworld Closes Acquisition of Madonna LTC Residence in Orleans, Ontario
[ Tue, Jul 17th 2012 ] - Market Wire
Select Medical Holdings Corporation to Announce Second Quarter 2012 Results on Tuesday, August 7
[ Tue, Jul 17th 2012 ] - Market Wire
Savient Pharmaceuticals to Hold Second Quarter 20 .. ults Conference Call on Wednesday, August 8, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
Skilled Healthcare to Release Second Quarter 2012 Results on August 8, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
Mylan Announces Settlement Agreement in Litigation Relating to its Generic Silenor
[ Tue, Jul 17th 2012 ] - Market Wire
CareFusion Provides Update On Voluntary Recall Of EnVe Ventilator
[ Tue, Jul 17th 2012 ] - Market Wire
InterMune To Release Second Quarter Financial Results On July 23
[ Tue, Jul 17th 2012 ] - Market Wire
The Lin Law Firm Investigates Potential Breaches .. tion With Proposed Acquisition of Par Pharmaceuti
[ Tue, Jul 17th 2012 ] - Market Wire
Vitamin D Supplementation May Not Reduce Cholesterol-Related Heart Disease Risk, New Study Finds
[ Tue, Jul 17th 2012 ] - Market Wire
Grifols Initiates Safety Study of Inhaled Alpha1- .. Following Orphan Drug Designation for Cystic Fibr
[ Tue, Jul 17th 2012 ] - Market Wire
Remedent Reports Fourth Quarter and Year End Resu .. ference Call at 12 PM EDT, Tuesday, July 17, 2012
[ Tue, Jul 17th 2012 ] - Market Wire
Stem Cell Therapeutics Annual General Meeting
[ Tue, Jul 17th 2012 ] - Market Wire
Implant Sciences Advances Global IP Protection Wi .. ent Covering Explosives Trace Detection in Russia
[ Tue, Jul 17th 2012 ] - Market Wire
BMR Previews Earnings for Intuitive Surgical, eBay, Chipotle, Kinder Morgan amp;; Others
[ Tue, Jul 17th 2012 ] - Market Wire
China Health Resource Develops Revolutionary Migraine Medication
[ Tue, Jul 17th 2012 ] - Market Wire
Soligenix Announces $600,000 NIAID SBIR Grant Awa .. ion of OrbeShielda" as a Treatment for Acute Radi
[ Tue, Jul 17th 2012 ] - Market Wire
Three More Leading Medical Centres Join VentriPoi .. entre Clinical Trial for Congenital Heart Disease
Mon, July 16, 2012
[ Mon, Jul 16th 2012 ] - Market Wire
Sequenom, Inc. Files Notice Of Appeal Of Preliminary Injunction Denial
[ Mon, Jul 16th 2012 ] - Market Wire
NuPathe Announces Migraine Patch NDA Resubmission
[ Mon, Jul 16th 2012 ] - Market Wire
Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012

Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012


Published on 2012-07-16 14:16:23 - Market Wire
  Print publication without navigation


Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012 -- MONTREAL, July 16, 2012 /PRNewswire/ --

Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012

[ ]
[ ]
[ ]

[ Download image ]

MONTREAL, July 16, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: [ VRX ]) (TSX: VRX) today announced that it will host a conference call and a live Internet webcast along with a slide presentation on Thursday, August 2, 2012 at 8:00 a.m. ET (5:00 a.m. PT) to discuss results for the 2012 second quarter.

The dial-in number to participate on this call is (877) 876-8393, confirmation code10552994.  International callers should dial (973) 200-3961, confirmation code 10552994. A replay will be available approximately two hours following the conclusion of the conference call to Thursday, August 8, 2012, and can be accessed by dialing (855) 859-2056 or (404) 537-3406, confirmation code 10552994.

The webcast and slide presentation will be hosted in the investor relations section of its corporate Web site at [ www.valeant.com ]. Participants should allow approximately five to 10 minutes prior to the call's start time to visit the site and to download any streaming media software needed to listen to the Internet webcast. An online archive of the webcast will be available following the end of the live call in the webcast archive portion of the investor relations section at [ www.valeant.com ].

About Valeant
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics.  More information about Valeant can be found at [ www.valeant.com ].

(Logo: [ http://photos.prnewswire.com/prnh/20101025/LA87217LOGO ])

Contact Information:
Laurie W. Little
949-461-6002
[ laurie.little@valeant.com ]

SOURCE Valeant Pharmaceuticals International, Inc.



[ Back to top ]

RELATED LINKS
[ http://www.valeant.com ]

Contributing Sources